CClinicalTrials.gg
CompletedNCT05732844Updated Feb 17, 2023

Efficacy of the Use of Vaginal Balls for the Improvement of Urinary Incontinence and Sexual Function in Women.

An interventional study of Intervention group with Enna pelvic ball and Control group in Urinary Incontinence, Stress Urinary Incontinence and Sexual Dysfunction, sponsored by RAPbarcelona. Completed at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-17.

Sponsored by RAPbarcelona · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Oct 2022, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Asess if adding vaginal spheres treatment to the conventional Pelvic Floor Muscle Trainning (PFMT) produces a greater decrease in the severity of the stress urinary incontinence or a greater perceived quality of life related to incontinence.

Read the detailed description

The intervention group will perform the pelvic floor muscle trainning (PFMT) plus the use of vaginal spheres, while the control group will perform the PFMT treatment only, daily at home. The study will be conducted on women with stress urinary incontinence. The intervention will last four months and will consist of a monthly session with the physiotherapist, doing a total of 4 sessions and the final assessment.

02

Conditions studied

  • Urinary Incontinence
  • Stress Urinary Incontinence
  • Sexual Dysfunction

Keywords

  • vaginal spheres
  • physiotherapy
  • pelvic floor muscle trainning
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

This study's enrollment of 64 is close to the median of 66 across 1,011 interventional studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

RAPbarcelona is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women aged 18 or over
  • Suffer from stress urinary incontinence or mixed urinary incontinence.
  • Understand Spanish to be able to self-complete the questionnaires (validated in Spanish).

Exclusion criteria

Exclusion Criteria:

  • Not giving informed consent.
  • Women with faecal incontinence.
  • Women with grade III-IV prolapse.
  • Women with pathology that can affect the neuro-muscular response.
  • Women with incontinence that is not of functional origin.
  • Women who have perineal pain that makes it impossible to apply the spheres.
  • Women with an open vagina of more than 2.5 cm opening
  • Being pregnant.
  • Not being committed to complying with a minimum of 80% of the treatment.
  • Having previously started other pelvic physiotherapy treatments
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (actual)

Study arms

  • Experimental
    Intervention group with Enna pelvic ball

    This group will receive instructions on how to carry out PFMT daily at home, and indications for the placement of Enna pelvic ball vaginal spheres daily.

    Device: Intervention group with Enna pelvic ball

  • Active comparator
    Control group

    This group will receive instructions on how to carry out PFMT daily at home.

    Other: Control group

Interventions

  • DeviceIntervention group with Enna pelvic ball

    The home guideline for placement of the vaginal spheres will be as described in next: st-2nd week 15 minutes, 1 time a day nd-4th week 30 minutes, 1 time a day 4th-8th week 1 hour, 1 time a day 8th-12th week 2 hours, 1 time a day 12th-16th week 3 hours, 1 time a day

  • OtherControl group

    According to the PERFECT score, a daily home guideline for the performance of PFMT will be requested three times a day, two types of exercises (endurance and strength), and eight repetitions of each.

06

What researchers measure

Primary outcomes

  1. Severity of urinary incontinence using the ICIQ-SF questionnaire (International Consultation on Incontinence Questionnaire Short form) at Week 16.

    The ICIQ-SF is a validated self-reported instrument assessing the urinary incontinence severity and It's quality of life. Possible scores range from 0 (no incontinence) to 21 (severe incontinence). Change=(Week 16 score - baseline score).

    Time frame: Time Frame: Baseline and Week 16

07

Study locations

1 site
  • RAPbarcelona SL
    Barcelona, 08037, Spain
08

References and documents

Publications

  • Oblasser C, Christie J, McCourt C. Vaginal cones or balls to improve pelvic floor muscle performance and urinary continence in women post partum: A quantitative systematic review. Midwifery. 2015 Nov;31(11):1017-25. doi: 10.1016/j.midw.2015.08.011. Epub 2015 Sep 9. PubMed 26428191 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05732844
Lead sponsor
RAPbarcelona
Responsible party
Inés Ramírez-García (Director, RAPbarcelona) — Principal investigator
First posted
Feb 17, 2023
Start date
Oct 5, 2022
Primary completion
Jan 27, 2023
Completion
Jan 27, 2023
Last update
Feb 17, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion